A single ascending dose study to investigate the tolerability and pharmacokinetics of NSD-788 in healthy volunteers

Trial Profile

A single ascending dose study to investigate the tolerability and pharmacokinetics of NSD-788 in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2008

At a glance

  • Drugs AN 788 (Primary)
  • Indications Anxiety disorders; Depressive disorders
  • Focus Adverse reactions
  • Sponsors NeuroSearch
  • Most Recent Events

    • 04 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top